IP Library Granted Patent US 9,566,072
Granted Patent B2
US 9,566,072 · App. 14/584,848 · Granted Feb 14, 2017

Coil system

Inventors: Jake Le (Foothill Ranch, CA); David Ferrera (Coto De Caza, CA); Dawson Le (Garden Grove, CA); Randall Takahashi (Mission Viejo, CA); George Martinez (Tustin, CA)
Assignee: BLOCKADE MEDICAL, LLC
A61B17/12113A61B17/12154A61B17/12172A61B2017/00526A61B2017/1205A61B2017/12063
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,566,072
App. No.
14/584,848
Granted
Feb 14, 2017
Kind
B2
Abstract

Vaso-impacting implants and novel methods of making coils, stent-trievers, flow diverters and the like enable aneurysm treatment, including in the brain. Refined and variegated framing and complex coils provide for rapid electrolytic detachment, including less than 20 second embodiments. Novel enhanced mandrels, fittings and winding schemes are likewise disclosed improving the standard of care and state of the art.

Claims (55)

1. A vasoocclusive implant comprising:

a metallic wire having a proximal end and a distal end and configured to transition from a constrained, deliverable configuration to a deployed, expanded configuration for the treatment of a vascular abnormality;

wherein, when in the constrained configuration, the metallic wire forms an elongate structure for delivery to a target site; and

wherein, upon delivery of the elongate helical coil structure to the target site, the metallic wire is configured to transition from the constrained configuration to the deployed configuration to form a three-dimensional structure for the treatment of the vascular abnormality, wherein the three-dimensional structure comprises a plurality of loops providing a multi-faceted and multi-angular outer surface configured to engage the vascular abnormality;

wherein the three-dimensional structure comprises:

a first loop having a first diameter and a second loop having a second diameter, the first and second loops generally arrayed along a first axis and spaced apart from each other by at least a dimension equal to the first diameter;

a third loop having a third diameter and a fourth loop having a fourth diameter, the third and fourth loops generally arrayed along a second axis and spaced apart from each other by at least a dimension equal to the third diameter; and

a fifth loop having a fifth diameter and a sixth loop having a sixth diameter, the fifth and sixth loops generally arrayed along a third axis and spaced apart from each other by at least a dimension equal to the fifth diameter;

wherein the first, second and third axes substantially approximate orthogonal lines, and

wherein the sixth diameter is between about 60% and 80% of the diameter of each of the first through fifth loop diameters.

2. A vasoocclusive implant comprising:

a metallic wire having a proximal end and a distal end and configured to transition from a constrained, deliverable configuration to a deployed, expanded configuration for the treatment of a vascular abnormality;

wherein, when in the constrained configuration, the metallic wire forms an elongate structure for delivery to a target site; and

wherein, upon delivery of the elongate helical coil structure to the target site, the metallic wire is configured to transition from the constrained configuration to the deployed configuration to form a three-dimensional structure for the treatment of the vascular abnormality, wherein the three-dimensional structure comprises a plurality of loops providing a multi-faceted and multi-angular outer surface configured to engage the vascular abnormality;

wherein the three-dimensional structure comprises:

a first loop having a first diameter and a second loop having a second diameter, the first and second loops generally arrayed along a first axis and spaced apart from each other by at least a dimension equal to the first diameter;

a third loop having a third diameter and a fourth loop having a fourth diameter, the third and fourth loops generally arrayed along a second axis and spaced apart from each other by at least a dimension equal to the third diameter; and

a fifth loop having a fifth diameter and a sixth loop having a sixth diameter, the fifth and sixth loops generally arrayed along a third axis and spaced apart from each other by at least a dimension equal to the fifth diameter;

wherein the first, second and third axes substantially approximate orthogonal lines, and

wherein the sixth diameter is between about 60% and 80% of the diameter of each of the first through fifth loop diameters, and wherein the first loop includes the first end of the metallic coil and the sixth loop includes the second end of the metallic coil.

3. A vasoocclusive implant comprising:

a metallic wire having a proximal end and a distal end and configured to transition from a constrained, deliverable configuration to a deployed, expanded configuration for the treatment of a vascular abnormality;

wherein, when in the constrained configuration, the metallic wire forms an elongate structure for delivery to a target site; and

wherein, upon delivery of the elongate helical coil structure to the target site, the metallic wire is configured to transition from the constrained configuration to the deployed configuration to form a three-dimensional structure for the treatment of the vascular abnormality, wherein the three-dimensional structure comprises a plurality of loops providing a multi-faceted and multi-angular outer surface configured to engage the vascular abnormality;

wherein the three-dimensional structure comprises:

a first loop having a first diameter and a second loop having a second diameter, the first and second loops generally arrayed along a first axis and spaced apart from each other by at least a dimension equal to the first diameter;

a third loop having a third diameter and a fourth loop having a fourth diameter, the third and fourth loops generally arrayed along a second axis and spaced apart from each other by at least a dimension equal to the third diameter; and

a fifth loop having a fifth diameter and a sixth loop having a sixth diameter, the fifth and sixth loops generally arrayed along a third axis and spaced apart from each other by at least a dimension equal to the fifth diameter; wherein the first, second and third axes substantially approximate orthogonal lines, and

wherein the sixth diameter is between about 60% and 80% of the diameter of each of the first through fifth loop diameters, and wherein the first loop includes the first end of the metallic coil and the sixth loop includes the second end of the metallic coil; and wherein the three-dimensional structure approximates a spheroid.

4. A vasoocclusive implant system comprising:

an elongate pushing member; and

a vasoocclusive implant comprising a metallic wire having a proximal end and a distal end, the implant coupled to the elongate pushing member via a detachable zone at the proximal end of the metallic wire, the metallic wire configured to transition from a constrained, deliverable configuration to a deployed, expanded configuration for the treatment of a vascular abnormality;

wherein, when in the constrained configuration, the metallic wire forms an elongate structure for delivery to a target site; and

wherein, upon delivery of the elongate helical coil structure to the target site a, the metallic wire is configured to transition from the constrained configuration to the deployed configuration to form a three-dimensional structure for the treatment of the vascular abnormality; wherein the three-dimensional structure comprises a plurality of loops providing a multi-faceted and multi-angular outer surface configured to engage the vascular abnormality and wherein the three-dimensional structure comprises:

a first loop having a first diameter and a second loop having a second diameter, the first and second loops generally arrayed along a first axis and spaced apart from each other by at least a dimension equal to the first diameter;

a third loop having a third diameter and a fourth loop having a fourth diameter, the third and fourth loops generally arrayed along a second axis and spaced apart from each other by at least a dimension equal to the third diameter; and

a fifth loop having a fifth diameter and a sixth loop having a sixth diameter, the fifth and sixth loops generally arrayed along a third axis and spaced apart from each other by at least a dimension equal to the fifth diameter; wherein the first, second and third axes substantially approximate orthogonal lines, and wherein the sixth diameter is between about 60% and 80% of the diameter of each of the first through fifth loop diameters.

5. A vasoocclusive implant system comprising:

an elongate pushing member; and

a vasoocclusive implant comprising a metallic wire having a proximal end and a distal end, the implant coupled to the elongate pushing member via a detachable zone at the proximal end of the metallic wire, the metallic wire configured to transition from a constrained, deliverable configuration to a deployed, expanded configuration for the treatment of a vascular abnormality;

wherein, when in the constrained configuration, the metallic wire forms an elongate structure for delivery to a target site; and

wherein, upon delivery of the elongate helical coil structure to the target site a, the metallic wire is configured to transition from the constrained configuration to the deployed configuration to form a three-dimensional structure for the treatment of the vascular abnormality; wherein the three-dimensional structure comprises a plurality of loops providing a multi-faceted and multi-angular outer surface configured to engage the vascular abnormality and wherein the three-dimensional structure comprises:

a first loop having a first diameter and a second loop having a second diameter, the first and second loops generally arrayed along a first axis and spaced apart from each other by at least a dimension equal to the first diameter

a third loop having a third diameter and a fourth loop having a fourth diameter, the third and fourth loops generally arrayed along a second axis and spaced apart from each other by at least a dimension equal to the third diameter; and

a fifth loop having a fifth diameter and a sixth loop having a sixth diameter; the fifth and sixth loops generally arrayed along a third axis and spaced apart from each other by at least a dimension equal to the fifth diameter; wherein the first, second and third axes substantially approximate orthogonal lines, and wherein the sixth diameter is between about 60% and 80% of the diameter of each of the first through fifth loop diameters;

wherein the first loop includes the first end of the metallic coil and the sixth loop includes the second end of the metallic coil.

6. A vasoocclusive implant system comprising:

an elongate pushing member; and

a vasoocclusive implant comprising a metallic wire having a proximal end and a distal end, the implant coupled to the elongate pushing member via a detachable zone at the proximal end of the metallic wire, the metallic wire configured to transition from a constrained, deliverable configuration to a deployed, expanded configuration for the treatment of a vascular abnormality;

wherein, when in the constrained configuration, the metallic wire forms an elongate structure for delivery to a target site; and

wherein, upon delivery of the elongate helical coil structure to the target site a, the metallic wire is configured to transition from the constrained configuration to the deployed configuration to form a three-dimensional structure for the treatment of the vascular abnormality; wherein the three-dimensional structure comprises a plurality of loops providing a multi-faceted and multi-angular outer surface configured to engage the vascular abnormality and wherein the three-dimensional structure comprises:

a first loop having a first diameter and a second loop having a second diameter, the first and second loops generally arrayed along a first axis and spaced apart from each other by at least a dimension equal to the first diameter;

a third loop having a third diameter and a fourth loop having a fourth diameter, the third and fourth loops generally arrayed along a second axis and spaced apart from each other by at least a dimension equal to the third diameter; and

a fifth loop having a fifth diameter and a sixth loop having a sixth diameter; the fifth and sixth loops generally arrayed along a third axis and spaced apart from each other by at least a dimension equal to the fifth diameter; wherein the first, second and third axes substantially approximate orthogonal lines, and wherein the sixth diameter is between about 60% and 80% of the diameter of each of the first through fifth loop diameters;

and, wherein the three-dimensional structure approximates a spheroid.

Assignments (5)
SECURITY INTEREST Recorded Jun 20, 2025
From: BALT USA, LLC
To: GLAS SAS
Reel/Frame 071474/0638 →
SECURITY INTEREST Recorded Jun 20, 2025
From: BALT USA, LLC
To: GLAS SAS
Reel/Frame 071474/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2025
From: BLOCKADE MEDICAL LLC
To: BALT USA, LLC
Reel/Frame 071031/0622 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2016
From: LE, JAKE; FERRERA, DAVID; LE, DAWSON; TAKAHASHI, RANDALL; MARTINEZ, GEORGE
To: BLOCKADE MEDICAL, LLC
Reel/Frame 039179/0418 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2015
From: LE, JAKE; FERRERA, DAVID; LE, DAWSON; TAKAHASHI, RANDALL; MARTINEZ, GEORGE
To: BLOCKADE MEDICAL, LLC
Reel/Frame 034633/0553 →
Continuity (2)
Provisional Application 61921338 · Dec 27, 2013
Related Publication 20150182227A1 · Jul 2, 2015